This trial will determine whether Cxbladder can help diagnose bladder cancer without missing any cases.
- Bladder Cancer
- Blood in Urine
1 Primary · 6 Secondary · Reporting Duration: The outcome measure will be assessed by 6 months after trial completion.
Awards & Highlights
2 Treatment Groups
Test, subjects categorised as "low risk" or "Not low risk"
1 of 2
1 of 2
600 Total Participants · 2 Treatment Groups
Primary Treatment: Test, subjects categorised as "low risk" or "Not low risk" · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
|Did not meet criteria||100.0%|
Why did patients apply to this trial?
- "havent currently tryed any drugs"
How many prior treatments have patients received?
Frequently Asked Questions
How many individuals are being monitored for this research endeavor?
"Completing the trial necessitates a total of 600 patients meeting all inclusionary requirements. Potential participants can register at Carolina Urologic Research Centre in Myrtle Beach, South Carolina or UT Southwestern Medical Center in Dallas, Texas and other locations." - Anonymous Online Contributor
How many health centers are carrying out this clinical trial?
"The current list of 10 medical centres taking part in this study includes the Carolina Urologic Research Center, UT Southwestern Medical Centre, and Milton S Hershey Penn State Division of Urology. Additionally, there are seven other locations running trials." - Anonymous Online Contributor
Are there any available openings to participate in this research?
"As of now, this trial is in search for participants. It was first posted on September 11th 2019 and the most recent modifications were made on September 20th 2022." - Anonymous Online Contributor